Member News
-
Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis
November 1, 2023 (Source) — Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences…
-
FendX Announces Issuance of a Patent in China to Protect REPELWRAP(TM) Film
November 1, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
-
Lithium Ionic Secures Grid Power Connection Contract with Cemig for Sustainable Electrification of the Bandeira Lithium Project, Minas Gerais, Brazil
October 31, 2023 (Source) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the…
-
Appia Reports Extraordinary Assay Drill Results From Its PCH Ionic Clay Project, Brazil
Reverse Circulation Drill Hole Returns 24 Metres Of Mineralization Averaging 27,188 ppm or 2.72% Total Rare Earth Oxides…
-
Australian Strategic Materials Quarterly Activities Report to 30 September 2023
QuarterlyActivitiesAppendix5BCashFlowReportDownload
-
Hemostemix’s 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease
October 30, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that Stem…
-
FendX’s Nanotechnology is Featured at Canadian Chemical Engineering Conference in Calgary, AB
October 30, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a nanotechnology company…
